Target intelligence / Profile preview

Pituitary-specific positive transcription factor 1 (PIT1)

Target: PIT1
Molecular classification: Transcription factor, DNA-binding protein

Overview

Pituitary-specific positive transcription factor 1 (PIT1, also known as POU1F1 or POU class 1 homeobox 1) is a sequence-specific DNA-binding transcription factor belonging to the POU family, critical for the development of the anterior pituitary gland and regulation of genes responsible for growth hormone, prolactin, and thyroid-stimulating hormone β expression[1][3][4]. Mutations in *POU1F1* result in pituitary hormone deficiencies and are implicated in diverse endocrine growth disorders, making *POU1F1* a vital molecular determinant in pituitary biology but not presently a direct therapeutic target in standard clinical practice[3][4].

Other names: POU class 1 homeobox 1POU1F1PIT1Growth hormone factor 1 (GHF-1)

Mechanism of action

no direct agents in clinical use modulate PIT1, though theoretical mechanisms would involve modulation of transcription factor activity

Biological functions

Regulation of pituitary developmentControl of growth hormone gene expressionActivation of prolactin and thyroid stimulating hormone β genesSpecification of lactotrope, somatotrope, and thyrotrope cell phenotypes

Disease associations

Pituitary hormone deficiency (combined or isolated)Growth hormone deficiencyOther pituitary developmental disorders

Safety considerations

Loss-of-function mutations lead to combined pituitary hormone deficiency, which may result in severe growth and metabolic abnormalities[3]

Biomarkers

Genetic mutations/polymorphisms in *POU1F1* as diagnostic/prognostic markers for pituitary hormone deficiencies[3]

Beyond the preview

Go deeper on Pituitary-specific positive transcription factor 1 (PIT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pituitary-specific positive transcription factor 1 (PIT1).

Explore the full profile